179 related articles for article (PubMed ID: 6202606)
21. Warm storage of whole blood for 72 hours.
Hughes JD; Macdonald VW; Hess JR
Transfusion; 2007 Nov; 47(11):2050-6. PubMed ID: 17958534
[TBL] [Abstract][Full Text] [Related]
22. Pathogen reduction of buffy coat platelet concentrates using riboflavin and light: comparisons with pathogen-reduction technology-treated apheresis platelet products.
Li J; de Korte D; Woolum MD; Ruane PH; Keil SD; Lockerbie O; McLean R; Goodrich RP
Vox Sang; 2004 Aug; 87(2):82-90. PubMed ID: 15355498
[TBL] [Abstract][Full Text] [Related]
23. [Survival of human isologous platelets labelled with chromium-51 after storage at room temperature (author's transl)].
López-Karpovitch X; Piedras J; Córdova MS
Sangre (Barc); 1981; 26(5-A):595-604. PubMed ID: 7323917
[No Abstract] [Full Text] [Related]
24. [The effect of the AcD-AG stabilizer on the survival time and surface properties of fluid preserved platelet concentrates compared to concentrates from fresh blood].
Preussner S; Frick G; Konrad H
Folia Haematol Int Mag Klin Morphol Blutforsch; 1977; 104(3):406-19. PubMed ID: 72028
[TBL] [Abstract][Full Text] [Related]
25. Storage of red cell concentrates in CPD-A2 for 42 and 49 days.
Beutler E; West C
J Lab Clin Med; 1983 Jul; 102(1):53-62. PubMed ID: 6854134
[TBL] [Abstract][Full Text] [Related]
26. The platelet adhesion capacity to subendothelial matrix and collagen in a flow model during storage of platelet concentrates for 7 days.
Boomgaard MN; Gouwerok CW; Homburg CH; de Groot G; IJsseldijk MJ; de Korte D
Thromb Haemost; 1994 Oct; 72(4):611-6. PubMed ID: 7878640
[TBL] [Abstract][Full Text] [Related]
27. Paired in vitro and in vivo comparison of apheresis platelet concentrates stored in platelet additive solution for 1 versus 7 days.
Shanwell A; Diedrich B; Falker C; Jansson B; Sandgren P; Sundkvist L; Svensson L; Vesterinen M; Gulliksson H
Transfusion; 2006 Jun; 46(6):973-9. PubMed ID: 16734814
[TBL] [Abstract][Full Text] [Related]
28. Cold storage of pooled, buffy-coat-derived, leucoreduced platelets in plasma.
Hornsey VS; Drummond O; McMillan L; Morrison A; Morrison L; MacGregor IR; Prowse CV
Vox Sang; 2008 Jul; 95(1):26-32. PubMed ID: 18393944
[TBL] [Abstract][Full Text] [Related]
29. Platelet capacity of various platelet pooling systems for buffy coat-derived platelet concentrates.
Dijkstra-Tiekstra MJ; Kuipers W; Setroikromo AC; de Wildt-Eggen J
Transfusion; 2008 Oct; 48(10):2114-21. PubMed ID: 18647365
[TBL] [Abstract][Full Text] [Related]
30. Active uptake of serotonin as viability parameter of stored platelets.
Benn HP; Ganschow I; Fischer R; Dresow B; Cassens U; Dittmer R; Kühnl P
Beitr Infusionsther Transfusionsmed; 1994; 32():84-7. PubMed ID: 9422104
[TBL] [Abstract][Full Text] [Related]
31. Interaction of long-term stored platelets with vascular subendothelium.
Escolar G; Hagert-Whiting K; Bravo ML; White JG
J Lab Clin Med; 1987 Feb; 109(2):147-54. PubMed ID: 3805866
[TBL] [Abstract][Full Text] [Related]
32. Characterization of blood components prepared from whole-blood donations after a 24-hour hold with the platelet-rich plasma method.
Thibault L; Beauséjour A; de Grandmont MJ; Lemieux R; Leblanc JF
Transfusion; 2006 Aug; 46(8):1292-9. PubMed ID: 16934062
[TBL] [Abstract][Full Text] [Related]
33. [Studies of thrombocyte function in CPD blood].
Frick G; Frick U; Preussner S; Förster HJ
Folia Haematol Int Mag Klin Morphol Blutforsch; 1978; 105(6):810-8. PubMed ID: 85593
[TBL] [Abstract][Full Text] [Related]
34. [Changes in platelet concentrates from dogs due to storage. I. Platelet count in in vitro function].
Klein A; Adamik A; Mischke R
Berl Munch Tierarztl Wochenschr; 1999; 112(6-7):243-53. PubMed ID: 10472723
[TBL] [Abstract][Full Text] [Related]
35. The effect of storage on platelet morphology.
Sturk A; Burt LM; Hakvoort T; ten Cate JW; Crawford N
Transfusion; 1982; 22(2):115-20. PubMed ID: 6461951
[TBL] [Abstract][Full Text] [Related]
36. Overnight or fresh buffy coat-derived platelet concentrates prepared with various platelet pooling systems.
Dijkstra-Tiekstra MJ; Kuipers W; Setroikromo AC; de Wildt-Eggen J
Transfusion; 2008 Apr; 48(4):723-30. PubMed ID: 18208415
[TBL] [Abstract][Full Text] [Related]
37. Evaluation of the Impact-R for monitoring the platelet storage lesion.
Albanyan AM; Murphy MF; Harrison P
Platelets; 2009 Feb; 20(1):1-6. PubMed ID: 19172514
[TBL] [Abstract][Full Text] [Related]
38. Extracellular accumulation of bioactive substances during preparation and storage of various platelet concentrates.
Edvardsen L; Taaning E; Dreier B; Christensen LD; Mynster T; Nielsen HJ
Am J Hematol; 2001 Jul; 67(3):157-62. PubMed ID: 11391711
[TBL] [Abstract][Full Text] [Related]
39. Manufacture of pooled platelets in additive solution and storage in an ELX container after an overnight warm temperature hold of platelet-rich plasma.
Alhumaidan H; Cheves T; Holme S; Sweeney JD
Am J Clin Pathol; 2011 Oct; 136(4):638-45. PubMed ID: 21917688
[TBL] [Abstract][Full Text] [Related]
40. In vitro evaluation of COM.TEC apheresis platelet concentrates using a preparation set and pathogen inactivation over a storage period of five days.
Moog R; Fröhlich A; Mayaudon V; Lin L
J Clin Apher; 2004; 19(4):185-91. PubMed ID: 15597347
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
